These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 32103057)

  • 41. Discovery of piperazin-1-ylpyridazine-based potent and selective stearoyl-CoA desaturase-1 inhibitors for the treatment of obesity and metabolic syndrome.
    Zhang Z; Sun S; Kodumuru V; Hou D; Liu S; Chakka N; Sviridov S; Chowdhury S; McLaren DG; Ratkay LG; Khakh K; Cheng X; Gschwend HW; Kamboj R; Fu J; Winther MD
    J Med Chem; 2013 Jan; 56(2):568-83. PubMed ID: 23245208
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Aberrant lipid metabolism in anaplastic thyroid carcinoma reveals stearoyl CoA desaturase 1 as a novel therapeutic target.
    von Roemeling CA; Marlow LA; Pinkerton AB; Crist A; Miller J; Tun HW; Smallridge RC; Copland JA
    J Clin Endocrinol Metab; 2015 May; 100(5):E697-709. PubMed ID: 25675381
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Loss of mitochondrial aconitase promotes colorectal cancer progression via SCD1-mediated lipid remodeling.
    You X; Tian J; Zhang H; Guo Y; Yang J; Zhu C; Song M; Wang P; Liu Z; Cancilla J; Lu W; Glorieux C; Wen S; Du H; Huang P; Hu Y
    Mol Metab; 2021 Jun; 48():101203. PubMed ID: 33676027
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Stearoyl-CoA desaturase activity modulates the activation of epidermal growth factor receptor in human lung cancer cells.
    Nashed M; Chisholm JW; Igal RA
    Exp Biol Med (Maywood); 2012 Sep; 237(9):1007-17. PubMed ID: 22946088
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Opportunities and challenges in developing stearoyl-coenzyme A desaturase-1 inhibitors as novel therapeutics for human disease.
    Zhang Z; Dales NA; Winther MD
    J Med Chem; 2014 Jun; 57(12):5039-56. PubMed ID: 24295027
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Knockout of Stearoyl-CoA Desaturase 1 Decreased Milk Fat and Unsaturated Fatty Acid Contents of the Goat Model Generated by CRISPR/Cas9.
    Tian H; Niu H; Luo J; Yao W; Chen X; Wu J; Geng Y; Gao W; Lei A; Gao Z; Tian X; Zhao X; Shi H; Li C; Hua J
    J Agric Food Chem; 2022 Apr; 70(13):4030-4043. PubMed ID: 35343224
    [TBL] [Abstract][Full Text] [Related]  

  • 47. SCD1 is associated with tumor promotion, late stage and poor survival in lung adenocarcinoma.
    Huang J; Fan XX; He J; Pan H; Li RZ; Huang L; Jiang Z; Yao XJ; Liu L; Leung EL; He JX
    Oncotarget; 2016 Jun; 7(26):39970-39979. PubMed ID: 27223066
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Stearoyl coenzyme A desaturase-1: multitasker in cancer, metabolism, and ferroptosis.
    Sen U; Coleman C; Sen T
    Trends Cancer; 2023 Jun; 9(6):480-489. PubMed ID: 37029018
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Stearoyl-CoA desaturase inhibitors: update on patented compounds.
    Liu G
    Expert Opin Ther Pat; 2009 Sep; 19(9):1169-91. PubMed ID: 19691439
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Stearoyl-CoA desaturase 1 inhibition impairs triacylglycerol accumulation and lipid droplet formation in colorectal cancer cells.
    Tracz-Gaszewska Z; Sowka A; Dobrzyn P
    J Cell Physiol; 2023 Dec; 238(12):2888-2903. PubMed ID: 37814830
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Discovery and pharmacological characterization of SAR707 as novel and selective small molecule inhibitor of stearoyl-CoA desaturase (SCD1).
    Voss MD; Zoller G; Matter H; Herling AW; Biemer-Daub G; Pfenninger A; Haag-Diergarten S; Keil S; Kohlmann M; Schmidts HL
    Eur J Pharmacol; 2013 May; 707(1-3):140-6. PubMed ID: 23524088
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evidence for an alternative fatty acid desaturation pathway increasing cancer plasticity.
    Vriens K; Christen S; Parik S; Broekaert D; Yoshinaga K; Talebi A; Dehairs J; Escalona-Noguero C; Schmieder R; Cornfield T; Charlton C; Romero-Pérez L; Rossi M; Rinaldi G; Orth MF; Boon R; Kerstens A; Kwan SY; Faubert B; Méndez-Lucas A; Kopitz CC; Chen T; Fernandez-Garcia J; Duarte JAG; Schmitz AA; Steigemann P; Najimi M; Hägebarth A; Van Ginderachter JA; Sokal E; Gotoh N; Wong KK; Verfaillie C; Derua R; Munck S; Yuneva M; Beretta L; DeBerardinis RJ; Swinnen JV; Hodson L; Cassiman D; Verslype C; Christian S; Grünewald S; Grünewald TGP; Fendt SM
    Nature; 2019 Feb; 566(7744):403-406. PubMed ID: 30728499
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibition of stearoylCoA desaturase activity blocks cell cycle progression and induces programmed cell death in lung cancer cells.
    Hess D; Chisholm JW; Igal RA
    PLoS One; 2010 Jun; 5(6):e11394. PubMed ID: 20613975
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fatty acid synthase and stearoyl-CoA desaturase-1 are conserved druggable cofactors of Old World Alphavirus genome replication.
    Bakhache W; Neyret A; McKellar J; Clop C; Bernard E; Weger-Lucarelli J; Briant L
    Antiviral Res; 2019 Dec; 172():104642. PubMed ID: 31678479
    [TBL] [Abstract][Full Text] [Related]  

  • 55. ELOVL5 Is a Critical and Targetable Fatty Acid Elongase in Prostate Cancer.
    Centenera MM; Scott JS; Machiels J; Nassar ZD; Miller DC; Zinonos I; Dehairs J; Burvenich IJG; Zadra G; Chetta PM; Bango C; Evergren E; Ryan NK; Gillis JL; Mah CY; Tieu T; Hanson AR; Carelli R; Bloch K; Panagopoulos V; Waelkens E; Derua R; Williams ED; Evdokiou A; Cifuentes-Rius A; Voelcker NH; Mills IG; Tilley WD; Scott AM; Loda M; Selth LA; Swinnen JV; Butler LM
    Cancer Res; 2021 Apr; 81(7):1704-1718. PubMed ID: 33547161
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Stearoyl-CoA desaturase-1 is a key factor for lung cancer-initiating cells.
    Noto A; Raffa S; De Vitis C; Roscilli G; Malpicci D; Coluccia P; Di Napoli A; Ricci A; Giovagnoli MR; Aurisicchio L; Torrisi MR; Ciliberto G; Mancini R
    Cell Death Dis; 2013 Dec; 4(12):e947. PubMed ID: 24309934
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition of stearoyl-CoA desaturase 1 expression induces CHOP-dependent cell death in human cancer cells.
    Minville-Walz M; Pierre AS; Pichon L; Bellenger S; Fèvre C; Bellenger J; Tessier C; Narce M; Rialland M
    PLoS One; 2010 Dec; 5(12):e14363. PubMed ID: 21179554
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Modulation of SCD1 activity in hepatocyte cell lines: evaluation of genomic stability and proliferation.
    de Lima Luna AC; Forti FL
    Mol Cell Biochem; 2021 Sep; 476(9):3393-3405. PubMed ID: 33954906
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Stearoyl-CoA desaturase-1 (SCD1) augments saturated fatty acid-induced lipid accumulation and inhibits apoptosis in cardiac myocytes.
    Matsui H; Yokoyama T; Sekiguchi K; Iijima D; Sunaga H; Maniwa M; Ueno M; Iso T; Arai M; Kurabayashi M
    PLoS One; 2012; 7(3):e33283. PubMed ID: 22413010
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Liver X receptor activation increases hepatic fatty acid desaturation by the induction of SCD1 expression through an LXRα-SREBP1c-dependent mechanism.
    Zhang X; Liu J; Su W; Wu J; Wang C; Kong X; Gustafsson JÅ; Ding J; Ma X; Guan Y
    J Diabetes; 2014 May; 6(3):212-20. PubMed ID: 23945440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.